Ask the broker two questions in writing today: is the offer still open, and what specifically changed in the underwriting file. Offers in this market carry stated expiration dates, commonly around thirty days, and every offer is conditional on re-verification of the insured’s health and the policy’s status before closing. If health improved between the assessment and the closing, the buyer is contractually entitled to reprice or withdraw, and they will. That is not bad faith; it is how the pricing works.
The counterintuitive part, and the reason people arrive at this page confused and sometimes angry, is that good medical news makes the offer smaller. A settlement buyer is purchasing a future death benefit and paying premiums until it arrives. Longer life means more premiums, a longer wait, and a lower present value. A stronger prognosis is therefore a negative in a pricing model even though it is the best possible outcome in every other part of your life. Anyone who told you otherwise was either being kind or was not being straight.
The right response to this news is usually not to chase a smaller offer. It is to step back and re-ask the underlying question — whether this policy should be kept, reduced, made paid up, or sold at all — because the facts that drove the original decision have changed materially. This page explains exactly how the number is produced, what specifically moves it, and how to think about the choice now.
In This Article
Check the Offer Status and What Triggered the Re-Underwriting
Write to the broker and ask for three things: the current status of each offer received, the date of each life expectancy report used, and a plain statement of what changed between the original assessment and now.
Offers go stale for ordinary reasons. Life expectancy reports have a practical shelf life; providers typically want an assessment supported by medical records no more than six to twelve months old, and many will require a refresh before funding. Policy conditions change too — a premium was paid, an illustration showed different charges, or the carrier updated its cost of insurance schedule.
What you need to isolate is whether the change is medical, documentary, or procedural. A medical change means the clinical picture genuinely improved: a tumor responded, an ejection fraction recovered, a transplant succeeded, a condition was reclassified. A documentary change means the underwriter now has records they did not have before — often a normal-looking recent office visit that reframed the file. A procedural change means nothing about your health moved at all and the offer simply expired or the buyer’s capital allocation shifted.
The three have different answers. Only the first genuinely means the policy is worth less. If you have already signed a purchase agreement, ask separately about the rescission window: under the NAIC Life Settlements Model Act adopted in most states, a seller may generally rescind within fifteen calendar days of receiving proceeds or thirty days from execution of the contract, whichever comes first. Confirm the exact figure for your state.
How a Life Expectancy Report Produces a Number
Understanding the machinery removes most of the mystery.
A provider orders reports from independent life expectancy underwriting firms — the recognized names in the field include ITM TwentyFirst, Fasano Associates, Predictive Resources, and AVS, among others. Each receives the medical records obtained under your HIPAA authorization and produces an opinion.
The opinion has two parts. First, a mortality multiplier expressed as a percentage of a base population. A multiplier of 100 percent means the insured is expected to experience mortality in line with the base table; 250 percent means two and a half times that rate. Second, a median life expectancy in months, derived by applying that multiplier to a standard mortality table. The industry benchmark is the Valuation Basic Table published by the Society of Actuaries, with the 2015 VBT in general use. See what the VBT is and how life expectancy underwriting works.
Providers typically obtain two reports and blend or average them. When the two diverge substantially — which happens more often than sellers expect — the pricing usually follows the more conservative one, meaning the longer life expectancy and the lower offer. Our page on what to do when two reports disagree covers that scenario.
The provider then models the policy: projected premiums to keep it in force through a distribution of possible death dates, the death benefit, and a target internal rate of return. Target returns in the low-to-mid teens have been typical in recent years, though they move with capital markets. Every additional month of expected life adds premium cost and pushes the benefit further into the future, and both effects reduce the price.
Why Better Health Means a Smaller Offer
Work a simplified example. A $1,000,000 universal life policy on a seventy-nine-year-old with an annual premium of $28,000 to keep it in force.
At a median life expectancy of sixty months, the buyer expects to pay roughly five years of premiums — about $140,000 — and receive $1,000,000. Discounted at a mid-teens required return, that supports a meaningful offer.
At a median life expectancy of one hundred and eight months, the buyer expects to pay roughly nine years of premiums, about $252,000, and to wait nearly twice as long for the same $1,000,000. The additional premium comes straight out of the price, and the longer discounting period compounds the reduction. Offers commonly fall by half or more on a change of that magnitude.
Three things follow from that arithmetic and they are worth stating explicitly.
First, the reduction is not a negotiating tactic. It is arithmetic that any buyer will reproduce, which is why shopping the same file to more providers after an LE extension rarely helps much.
Second, the premium level matters as much as the life expectancy. A policy with a low premium relative to its death benefit — a well-funded whole life contract, or a universal life policy with a favorable cost structure — holds its value far better across an LE extension than a policy with expensive cost-of-insurance charges.
Third, the face amount is unchanged. The death benefit your family would receive if you keep the policy did not shrink by a dollar. Only the discounted price a stranger will pay for it today moved. That distinction is the entire basis of the decision described below. Related: why improved health lowers an offer and reading a life expectancy report.
| Change | Effect on Life Expectancy | Effect on Offer | Effect on Death Benefit If You Keep It |
|---|---|---|---|
| Cancer enters remission | Extends, often substantially | Falls sharply or offers withdraw | None; face amount unchanged |
| Successful cardiac procedure | Extends | Falls | None |
| Recent routine physical with stable findings | Extends modestly | Falls modestly | None |
| New comorbidity documented | Shortens | Rises | None |
| Carrier raises cost of insurance | No change | Falls; more premium to carry | Higher cost to keep the policy |
| Offer simply expired | No change | May be reissued at similar terms | None |
What Actually Changed: Diagnosis, Treatment, or Documentation
Before accepting that the file is worth less, find out what moved. Ask the broker to identify the specific records that changed the assessment. You are entitled to understand your own file.
A genuine clinical improvement. Cancer in remission after a course of therapy. Cardiac function recovered following a procedure. A successful transplant. Weight loss and medication changes that reversed a diabetic trajectory. These are real and the pricing consequence is real.
A newer, healthier-looking record. This one is subtler and it catches people. Underwriters weight recent records heavily. A routine annual physical in which a physician wrote that the patient was doing well, was ambulatory, and had stable vitals can meaningfully extend a life expectancy even when the underlying serious condition is unchanged. The chart described a good day, and the model read it as a trend.
A missing record found. Sometimes the first assessment was made on an incomplete file and the addition of a specialist’s notes changed the picture in either direction.
A reclassification. Staging revised, a diagnosis corrected, a comorbidity ruled out.
Where the change came from documentation rather than from clinical reality, there is a legitimate path: ask the treating physician’s office whether the record accurately reflects the patient’s functional status, and whether an updated note or an attending physician statement would present a more complete picture. This is not about influencing an outcome; it is about ensuring the underwriter sees the full file. A patient’s actual functional status — activities of daily living, hospitalizations, medication burden — is what underwriters most want and most often lack.
Ranking the Options Now
- Keep the policy. With a longer life expectancy, this option got better, not worse. The full death benefit is intact, it remains income-tax-free to beneficiaries under Internal Revenue Code section 101(a), and the reason to sell — a short horizon and a premium burden — is now weaker. If the premiums are affordable, keeping is frequently the correct answer and it should be considered first, not last.
- Reduce the face amount. If the premium is the pressure point, most carriers will reduce coverage on request and cut the premium proportionally, preserving the contract and its original issue-age pricing.
- Reduced paid-up. Ends premiums permanently in exchange for a smaller, fully paid policy. Better suited than ever to someone with a longer horizon, because there is no lapse risk to manage for the rest of a longer life.
- Extended term. Full face amount for a defined period with no further premiums. Worth quoting, though a longer life expectancy makes outliving the term a more serious risk.
- Policy loan. A bridge if the need for cash is real and temporary. Interest compounds, and over a longer life that compounding matters more.
- Accept a reduced offer. Legitimate if the policy was genuinely going to lapse and the reduced number still exceeds the surrender value by a worthwhile margin. Compare against the cash surrender value in writing before deciding. See what to do about a low offer.
- Get a second opinion on the pricing. Different providers use different underwriters and different capital costs, and the spread between offers on the same file is sometimes wide. See getting a second opinion.
- 1035 exchange. Occasionally useful if the existing contract’s cost structure is the real problem, but it restarts surrender charges and does not create cash.
- Surrender. Last. Any offer that beats surrender value is by definition better, and the nonforfeiture options usually beat both.
When Selling Is the Wrong Answer
The improvement is real and the premium is affordable. A longer expected life with manageable premiums is the textbook case for keeping a policy. You are being offered a discounted price for a benefit you now have more time to protect for your family. Take the good news at face value.
The reduced offer barely beats surrender value. A settlement is worth the paperwork, the medical disclosure, and the years of contact from a tracking agent when the premium over surrender value is substantial. When the gap narrows to a few thousand dollars, the transaction stops being worth its own friction.
Nobody has priced the nonforfeiture options. Reduced paid-up and extended term quotations are free to request and take a phone call. Deciding between a diminished offer and a surrender without having those two numbers in hand is deciding without the relevant information.
You are being pressured to close before a re-verification. Any party urging you to sign quickly because the offer might drop again is telling you something about themselves. Legitimate transactions survive a week of consideration and a conversation with your own advisor.
Someone suggests presenting the file selectively. Withholding or shaping medical records to secure a better price is fraud, it voids the transaction, and it is a matter for the state insurance department. Providing a complete and accurate file, including records that help the underwriter understand functional status, is the correct and legal version of the same instinct.
Means-tested benefits are in play. Proceeds are countable resources for Supplemental Security Income and Medicaid. A smaller lump sum can still disqualify without delivering enough to matter.
If the answer is to revisit this later, that is a perfectly good outcome. Life expectancy assessments can be re-run when the clinical picture changes, and files that were unattractive one year have been repriced in another. Our pages on shopping a policy a second time and timing a sale cover how that works. In the meantime, a free policy review will establish what the contract is worth kept, reduced, made paid up, or surrendered, using only the policy cover page, the schedule of riders, and a recent annual statement — which is the comparison the original quote was always supposed to be measured against.
Frequently Asked Questions
Why did my offer drop when my doctor gave me good news?
Buyers pay premiums until the death benefit is collected, so a longer expected life means more premiums and a longer wait for the same amount of money. Both effects reduce present value. The face amount your beneficiaries would receive is unchanged; only the discounted price a buyer will pay today moved.
Can the buyer withdraw an offer after I accepted it?
Typically yes, before funding. Offers are conditional on re-verification of the insured’s health and the policy’s status, and purchase agreements normally allow repricing or withdrawal if the underwriting basis changes. That is why sellers should never make financial commitments against expected proceeds until escrow has actually funded.
Should I get another life expectancy report?
Only if you have reason to believe the existing ones misread your file, such as missing specialist records or a chart entry that misstates functional status. Ordering more reports on the same records generally produces the same answer and costs time. Ask the broker first which specific records drove the change.
Is it worth shopping the policy to other providers now?
Sometimes. Providers use different underwriting firms and have different capital costs, so spreads on the same file can be meaningful. But an extended life expectancy affects every buyer’s model the same way, so expect improvement at the margin rather than a return to the original number. Compare any result against surrender value.
Can I ask my doctor to write a letter about my condition?
You can ask the treating physician whether the record accurately reflects functional status and whether an attending physician statement would present a fuller picture. That is legitimate. Shaping or withholding records to obtain a higher price is fraud, voids the transaction, and is reportable to your state insurance department.
If I decide not to sell, what should I do instead?
Price the alternatives in writing: current cash surrender value, the reduced paid-up face amount, the extended term period, and what a reduced face amount would cost per year. All four quotations are free to request from the carrier. With a longer life expectancy, keeping the policy in some form is frequently the stronger outcome.
Find out what your policy is worth — free, confidential, no obligation.
A 15-minute educational review covers your eligibility, every alternative, and a realistic view of what each path would net you.
Related Reading
- Improved Health Lower Offer
- Two Le Reports Differ
- Life Expectancy Report Explained
- What Is Life Expectancy Underwriting
- What Is The Vbt Mortality Table
- Low Offer What To Do
- Second Opinion On An Offer
- Shopping A Policy Twice
- Timing When To Sell A Policy
Pine Lake Life Solutions does not purchase life insurance policies and does not provide legal, tax, or investment advice. Information provided is for educational purposes only. Eligibility for any option, including life settlements, is not guaranteed and depends on individual circumstances, policy terms, underwriting, and market conditions. Consult independent legal, tax, or financial professionals before making decisions regarding a life insurance policy.